Successful oncolytic virus immunotherapy clinical development requires unique features that focus on viral biology and host immune response.
News
Advertisement
Advertisement
Steps that investigators and sponsors can take to streamline trials and accelerate the time to market for lifesaving therapies.
Advertisement
Advertisement
The latest happenings of the past month, all in one place.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
3
Moving Beyond Historical Site Data to Real-Time Patient Insight
4
The Challenges of Buying Blind: Why Providing the Clinical Outcome Assessment Measure Prior to License Execution Would Significantly Benefit Clinical Trial Set-Up
5